ROP vs SPXC: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: ROP is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ROP and SPXC share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ROP and SPXC exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Roper Technologies has spent the past decade reinventing itself from an industrial tools and equipment maker into a diversified holding company whose center of gravity is vertical-market software. It operates through three segments: Application Software (businesses like Deltek for government contractors, Vertafore in insurance, Aderant for law firms, Frontline in K-12 education, and Clinisys in diagnostics), Network Software (network-effect platforms such as DAT in freight and iPipeline in insurance), and Technology Enabled Products (Neptune water meters, Verathon and CIVCO in medical devices). More than half of total revenue is now recurring, coming from SaaS subscriptions, maintenance and transaction fees, and application plus network software together generate roughly three-quarters of revenue.

Full ROP guide

SPX Technologies is a diversified industrial manufacturer headquartered in Charlotte, North Carolina, that engineers and sells specialized equipment through two reporting segments. The HVAC segment makes package and process cooling products, cooling towers, fluid coolers, and engineered air-movement and heating solutions under brands including Marley, Recold, SGS, Cincinnati Fan, TAMCO, and Ingenia. The Detection and Measurement segment sells underground pipe and cable locators, pipeline inspection and robotic systems, transit fare-collection systems, communications technologies, and aids-to-navigation products under brands like Radiodetection, CUES, ULC Robotics, Genfare, and Sealite. This mix gives SPX exposure to long-cycle infrastructure, utility, and building markets rather than a single commodity or end product.

Full SPXC guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• ROP drivers: Acquisition-driven compounding; Recurring, high-margin software mix.
• SPXC drivers: Data-center cooling tailwind; Serial-acquisition playbook.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The clearest risk is valuation: ROP trades at a premium multiple, so disappointing results or a slower deal pace can compress the stock even if the business stays healthy. For SPXC, the most immediate risk is valuation: SPX trades at a premium industrial multiple that assumes continued double-digit growth and margin expansion, so any demand slowdown or execution stumble can compress the multiple quickly.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ROP if you believe its drivers more; SPXC if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ROP and SPXC guides.

ROP. Roper's Q1 2026 revenue rose about 11% year over year to roughly $2.10 billion, split between 6% organic growth and 5% from acquisitions, and it raised full-year adjusted earnings guidance while adding to its buyback authorization. Net margins sit near 19% to 20% and adjusted EBITDA margins around 38%, reflecting the software-heavy mix. The forward multiple in the mid-to-high teens is well below the stock's longer-run median, which bulls read as more reasonable and bears view as still-full for a business dependent on ongoing M&A.

SPXC. These are qualitative characterizations tied to the asOf date, not precise live figures; confirm current numbers before acting. The key tension is that SPX's fundamentals have genuinely improved (faster growth, higher margins, a clearer data-center story), but the stock's premium valuation already reflects much of that, so the multiple offers less protection if growth decelerates. For a cyclical, acquisition-driven industrial, the durability of organic demand and deal execution matters more than any single quarter's beat.

Headline figures (approximate, JULY 2026): ROP shows revenue (ttm) ~$8.0 billion, q1 2026 revenue ~$2.10 billion (up ~11% YoY), market cap ~$35-36 billion, fy2026 adjusted deps guidance ~$21.80-$22.05; SPXC shows revenue trend Growing double digits; Q1 2026 revenue up ~17% to ~$567 million, 2025 full-year ~$2.27 billion, earnings trend Rising; Q1 2026 adjusted EBITDA up ~23%, GAAP EPS up ~15%, with a Q1 beat versus estimates, 2026 guidance Raised during Q1; management lifted revenue, adjusted EBITDA, and adjusted EPS ranges, margins Expanding; adjusted EBITDA growing faster than revenue, reflecting operating leverage and mix.

ROP and SPXC are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ROP and SPXC exposure against your real portfolio. It is not an investment adviser.